the future of glp 1 drugs GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 for Drug Addiction |
Description
The LEADER-6 study shown substantial cardiovascular advantages of liraglutide in high-risk patients, while SUSTAIN-6 revealed a significant decrease in cardiovascular event-related mortality with subcutaneous semaglutide (Verma et al
These side effects may recur when the person titrates the dose, Dawkins says
This is not pathological
The study identified 1,799,261 patients with diabetes prescribed metformin, of which 1,083,492 (60.2%) had neither OSA diagnosis nor GLP-1 prescription
Currently, there are 9 GLP-1RAs approved by the FDA, widely used for the treatment of type 2 diabetes
Sattar N, McGuire DK, Pavo I, et al
